Prospective study for detect the daily activity and efficacy of medication of COPD patients using wearable watch type sensor.

Prospective study for detect the daily activity and efficacy of medication of COPD patients using wearable watch type sensor. - Ditection of daily activity of COPD patients using uearable sensor.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000037646

Enrollment

120

Registered

2019-08-13

Start date

2019-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease (COPD)

Interventions

Comparison between LAMA and LAMA,LABA. All the patients will be administered LAMA (Tiotropium) for 6 weeks. Comparison between LAMA and LAMA,LABA. All the patients will be administered LAMA (Tiotrop

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: COPD patients.

Exclusion criteria

Exclusion criteria: Other pulmonary diseases like lung cancer interstitial pneumonia, pulmonary infection and so on.

Design outcomes

Primary

Measure	Time frame
Daily activity for 6 weeks with the test drugs.	—

Secondary

Measure	Time frame
Daily activity for 3 weeks with observational period. Time coarse of CAT score and mMRC score.	—

Countries

Japan

Contacts

Public ContactMotokazu Kato

Kishiwada City Hospital Chest Disease Clinical and Research Institute

kch-43@kishiwada-hospital.com072-445-1000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026